[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620751":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":52,"collaborators":25,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":56,"sex":62,"minAge":63,"maxAge":25,"enrollmentInfo":64,"targetDuration":25,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Polyclinique de l'Europe","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patient group receiving tDCS stimulation","EXPERIMENTAL","Progressive increase in stimulation intensity up to 2 mA, then continuation at a plateau for a total of 20 minutes, then a decrease in stimulation intensity for 30 seconds at the end of the session before an automatic stop.",[13],"Other: transcranial direct current stimulation",{"label":15,"type":16,"description":17,"interventionNames":18},"Patient group receiving tDCS placebo stimulation","PLACEBO_COMPARATOR","Control group : The stimulation intensity is gradually increased up to 2 mA for 1 minute, then decreased to zero stimulation. A further increase in stimulation is programmed 10 minutes after the start of stimulation.",[19],"Other: Placebo",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"transcranial direct current stimulation","progressive increase in stimulation intensity up to 2 mA, then continuation at a plateau for a total of 20 minutes, then a decrease in stimulation intensity for 30 seconds at the end of the session before an automatic stop.",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo","The stimulation intensity is gradually increased up to 2 mA for 1 minute, then decreased to zero stimulation. A further increase in stimulation is programmed 10 minutes after the start of stimulation.",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Valentin Billard","CONTACT","02 51 16 16 16","vbillard@vivalto-sante.com",[37],{"facility":5,"status":38,"city":39,"state":25,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Saint-Nazaire","44600","France","FR",{"type":44,"coordinates":45},"Point",[46,47],-2.2179,47.27506,{"lat":47,"lon":46},[50],{"name":51,"role":33,"phone":34,"phoneExt":25,"email":35},"Valentin BILLARD",{"type":53,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100620751","effectiveness-of-transcranial-direct-current-stimulation-tdcs-in-the-management-of-complex-regional-pain-syndrome-100620751",false,"NCT07361692","Effectiveness of Transcranial Direct Current Stimulation (tDCS) in the Management of Complex Regional Pain Syndrome","Study of the Effectiveness of Transcranial Direct Current Stimulation (tDCS) in the Management of Complex Regional Pain Syndrome","ALGOSTIM","Inclusion Criteria:\n\n* Major\n* Clinically active or active complex regional pain syndrome (CRPS) with positive Budapest criteria\n* Scintigraphy showing signs consistent with CRPS\n* Being affiliated with or a beneficiary of a social security scheme\n\nExclusion Criteria:\n\n* Algodystrophy no longer meeting the Budapest criteria\n* Relative contraindication to tDCS: psychosis (including treated psychosis), uncontrolled epilepsy, large scalp scar, intracerebral\u002Fintracranial metallic body\n* Pregnant or breastfeeding women\n* Minors\n* Persons under legal protection (guardianship, conservatorship, and protective supervision)\n* Persons deprived of their liberty by judicial or administrative order\n* Unwilling individuals who cannot give their consent or cannot return for scheduled visits according to the protocol","ALL","18 Years",{"count":65,"type":66},32,"ESTIMATED","INTERVENTIONAL",[69],"NA","Transcranial direct current stimulation (tDCS) is a non-invasive therapy increasingly used in facilities treating patients with chronic pain. This complementary therapy has the advantage of being non-pharmacological, with transient and mild side effects, an excellent safety profile, and good efficacy in the contexts where it has been the subject of dedicated research: neuropathic pain, fibromyalgia, and visceral pain. Few studies have focused on the application of tDCS in the context of complex regional pain syndrome (CRPS), which is a common condition.",[72],"Complex Regional Pain Syndrome (CRPS)",[74,75,76,77,78,79],"Transcranial direct current stimulation","Complex Regional Pain Syndrome","pain","quality of life","anxiety","central sensitization","2026-06-17",{"date":82,"type":83},"2026-06-18","ACTUAL",{"date":85,"type":83},"2026-04-01",{"date":87,"type":66},"2027-06",{"name":5,"class":6},1]